Total Payments
$3,591
2024 Payments
$459.64
Companies
26
Transactions
185
Medicare Patients
3,328
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$3,394 (94.5%)
Education$197.10 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,394 | 178 | 94.5% |
| Education | $197.10 | 7 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $663.10 | 34 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $491.76 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $370.24 | 20 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $288.33 | 14 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $276.17 | 20 | $0 (2023) |
| Relypsa, Inc. | $230.15 | 12 | $0 (2019) |
| Fresenius USA Marketing, Inc. | $228.89 | 13 | $0 (2024) |
| Daiichi Sankyo Inc. | $167.50 | 9 | $0 (2022) |
| Aurinia Pharma U.S., Inc. | $126.72 | 5 | $0 (2024) |
| Baxter Healthcare | $122.78 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $459.64 | 21 | Fresenius USA Marketing, Inc. ($84.64) |
| 2023 | $384.82 | 18 | Bayer Healthcare Pharmaceuticals Inc. ($128.03) |
| 2022 | $694.46 | 35 | Bayer HealthCare Pharmaceuticals Inc. ($142.08) |
| 2021 | $227.45 | 11 | Amgen Inc. ($74.74) |
| 2020 | $110.52 | 6 | AstraZeneca Pharmaceuticals LP ($22.62) |
| 2019 | $945.58 | 50 | Otsuka America Pharmaceutical, Inc. ($246.69) |
| 2018 | $383.34 | 21 | Amgen Inc. ($124.13) |
| 2017 | $385.06 | 23 | Amgen Inc. ($127.60) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/07/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: NEPHROLOGY | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Rare Disease | ||||||
| 08/01/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: NEPHROLOGY | ||||||
| 07/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/10/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/09/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Hyperkalemia | ||||||
| 03/14/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/05/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/05/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $13.63 | General |
| 12/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardio-renal | ||||||
| 10/02/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: KRYSTEXXA | ||||||
| 08/19/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/08/2023 | Amgen Inc. | Parsabiv (Drug), TAVNEOS | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 820 | 2,241 | $702,675 | $246,504 |
| 2022 | 15 | 730 | 1,593 | $592,522 | $191,677 |
| 2021 | 13 | 653 | 1,736 | $622,259 | $263,728 |
| 2020 | 16 | 1,125 | 2,788 | $985,288 | $342,987 |
Total Patients
3,328
Total Services
8,358
Medicare Billing
$1.0M
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 50 | 316 | $267,100 | $87,796 | 32.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 142 | 333 | $75,162 | $31,853 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 317 | $96,979 | $29,146 | 30.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 17 | 95 | $62,498 | $21,793 | 34.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 232 | $24,676 | $11,584 | 46.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 79 | 175 | $31,536 | $11,083 | 35.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 74 | 78 | $30,815 | $10,879 | 35.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 28 | 38 | $23,988 | $8,945 | 37.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 27 | 53 | $26,599 | $8,410 | 31.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 44 | 192 | $18,209 | $7,487 | 41.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 40 | 176 | $18,092 | $7,028 | 38.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 35 | $8,996 | $3,664 | 40.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 22 | 79 | $6,239 | $2,511 | 40.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 53 | $4,312 | $2,016 | 46.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 21 | 30 | $5,815 | $1,721 | 29.6% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 39 | 39 | $1,658 | $587.86 | 35.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 39 | 207 | $170,729 | $57,815 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 365 | $110,787 | $35,447 | 32.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 117 | 276 | $66,180 | $22,228 | 33.6% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 13 | 85 | $63,473 | $20,243 | 31.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 36 | 61 | $40,417 | $14,021 | 34.7% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 35 | 74 | $49,192 | $11,783 | 24.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 57 | 63 | $29,060 | $9,943 | 34.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 57 | 132 | $23,047 | $7,619 | 33.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 110 | $19,088 | $6,236 | 32.7% |
About Dr. Anna Schuler, MD
Dr. Anna Schuler, MD is a Internal Medicine healthcare provider based in Austell, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609938133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Schuler, MD has received a total of $3,591 in payments from pharmaceutical and medical device companies, with $459.64 received in 2024. These payments were reported across 185 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,394).
As a Medicare-enrolled provider, Schuler has provided services to 3,328 Medicare beneficiaries, totaling 8,358 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Austell, GA
- Active Since 12/14/2006
- Last Updated 01/14/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609938133
Products in Payments
- SAMSCA (Drug) $355.71
- Kerendia (Drug) $288.33
- Veltassa (Drug) $272.16
- LOKELMA (Drug) $250.18
- Velphoro (Drug) $228.89
- Rayaldee (Drug) $219.39
- Parsabiv (Biological) $175.68
- INJECTAFER (Drug) $167.50
- Parsabiv (Drug) $162.25
- ACTHAR (Biological) $142.60
- JYNARQUE (Drug) $136.05
- LUPKYNIS (Drug) $126.72
- Renal - PD (Device) $122.78
- TAVNEOS (Drug) $110.50
- Repatha (Biological) $101.48
- FARXIGA (Drug) $81.06
- Auryxia (Drug) $69.98
- Prolia (Biological) $57.67
- RAYALDEE (Drug) $56.78
- KRYSTEXXA (Biological) $49.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Austell
Dr. Gretchen Anderson, D.o, D.O
Internal Medicine — Payments: $12,379
Internal Medicine $12,379
Dr. Christopher Stanke, M.d, M.D
Internal Medicine — Payments: $7,934
Internal Medicine $7,934
Aseem Shrivastava, Md, MD
Internal Medicine — Payments: $7,676
Internal Medicine $7,676
Dr. John Williams, M.d, M.D
Internal Medicine — Payments: $7,460
Internal Medicine $7,460
Tenecia Allen, M.d, M.D
Internal Medicine — Payments: $6,811
Internal Medicine $6,811
Dr. Ketan Desai, Do, DO
Internal Medicine — Payments: $6,059
Internal Medicine $6,059